Bio Europe Spring 2021へ参加
GN Corporation is participating in Bio Europe Spring 2021.
Bio Europe Spring 2021へ参加 Read More »
News
Nichi Glucan has been published in NutraIngredients-Asia
Our product, Nichi glucan, has been published in N…
Nichi Glucan has been published in NutraIngredients-Asia Read More »
GN Corporation was featured in Eurobiz Japan
GN Corporation was featured in a business magazine as one of the companies with sustainable production.
GN Corporation was featured in Eurobiz Japan Read More »
Initiation of joint research with Oakyama University
Dr. Senthil Kumar Rajappa, whose arrival in Japan …
Initiation of joint research with Oakyama University Read More »
Biotech Showcase 2021
GN Corporation is participating in Biotech Showcase 2021.
Biotech Showcase 2021 Read More »
A paper on the potential of Nichi Glucan to prevent complications of coronavirus infection has been published in a journal.
It argues that Nichiglucan may prevent complications by balancing blood sugar, lipids, and blood clotting.
Obtained Japanese patent for A method of enhancement of the immune cells and blood cells
GN Corporation Co Ltd obtained a Japanese patent N…
Obtained Japanese patent for A method of enhancement of the immune cells and blood cells Read More »
Participation in CHINA BIO, BIO PHAMA AMERICA and BIO EUROPE
GN Corporation has been selected for JETRO’s participation support program and attends digital exhibitions.
Participation in CHINA BIO, BIO PHAMA AMERICA and BIO EUROPE Read More »
An article on Nichi Glucan was published in Forbes Central America
The article on “Immune response to taking be…
An article on Nichi Glucan was published in Forbes Central America Read More »